Hemogenyx Pharmaceuticals Valuation
| HOPHF Stock | USD 0 0.00 0.00% |
Hemogenyx Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Hemogenyx Pharmaceuticals from evaluating the firm fundamentals such as Shares Owned By Insiders of 13.01 %, return on equity of -0.32, and Return On Asset of -0.18 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Hemogenyx Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Hemogenyx Pharmaceuticals is based on 3 months time horizon. Increasing Hemogenyx Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Hemogenyx pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Hemogenyx Pharmaceuticals Plc. Since Hemogenyx Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Hemogenyx Pink Sheet. However, Hemogenyx Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0031 | Real 0.002604 | Hype 0.0031 | Naive 0.0031 |
The real value of Hemogenyx Pink Sheet, also known as its intrinsic value, is the underlying worth of Hemogenyx Pharmaceuticals Company, which is reflected in its stock price. It is based on Hemogenyx Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Hemogenyx Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Hemogenyx Pharmaceuticals Plc helps investors to forecast how Hemogenyx pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hemogenyx Pharmaceuticals more accurately as focusing exclusively on Hemogenyx Pharmaceuticals' fundamentals will not take into account other important factors: Hemogenyx Pharmaceuticals Total Value Analysis
Hemogenyx Pharmaceuticals Plc is currently forecasted to have takeover price of 8.17 M with market capitalization of 45.68 M, debt of 10.15 K, and cash on hands of 6.84 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Hemogenyx Pharmaceuticals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.17 M | 45.68 M | 10.15 K | 6.84 M |
Hemogenyx Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Hemogenyx is to check how much profit was generated for every dollar of assets it reports. Hemogenyx Pharmaceuticals retains a negative application of resources of -0.18 (percent), losing $0.001771 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of Hemogenyx Pharmaceuticals Plc shows how discouraging it operates for each dollar spent on its resources.Hemogenyx Pharmaceuticals Ownership Allocation
Hemogenyx Pharmaceuticals Plc has a total of 1.14 Billion outstanding shares. Hemogenyx Pharmaceuticals retains 13.01 (percent) of its outstanding shares held by insiders and 0.0 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Hemogenyx Pharmaceuticals Profitability Analysis
Net Loss for the year was (5.1 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Hemogenyx Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Hemogenyx Pharmaceuticals and how it compares across the competition.
About Hemogenyx Pharmaceuticals Valuation
The pink sheet valuation mechanism determines Hemogenyx Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Hemogenyx Pharmaceuticals. We calculate exposure to Hemogenyx Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Hemogenyx Pharmaceuticals's related companies.Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. The company was founded in 2012 and is headquartered in London, the United Kingdom. Hemogenyx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 10 people.
8 Steps to conduct Hemogenyx Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Hemogenyx Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Hemogenyx Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Hemogenyx Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Hemogenyx Pharmaceuticals' revenue streams: Identify Hemogenyx Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Hemogenyx Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Hemogenyx Pharmaceuticals' growth potential: Evaluate Hemogenyx Pharmaceuticals' management, business model, and growth potential.
- Determine Hemogenyx Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Hemogenyx Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Hemogenyx Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Hemogenyx Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 979.7 M | |
| Retained Earnings | -13.1 M |
Complementary Tools for Hemogenyx Pink Sheet analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |